PL1879909T3 - Roztwór albuminy pozbawiony cząsteczek stabilizatora - Google Patents

Roztwór albuminy pozbawiony cząsteczek stabilizatora

Info

Publication number
PL1879909T3
PL1879909T3 PL06763120T PL06763120T PL1879909T3 PL 1879909 T3 PL1879909 T3 PL 1879909T3 PL 06763120 T PL06763120 T PL 06763120T PL 06763120 T PL06763120 T PL 06763120T PL 1879909 T3 PL1879909 T3 PL 1879909T3
Authority
PL
Poland
Prior art keywords
albumin solution
stabilizer molecule
depleted
depleted albumin
stabilizer
Prior art date
Application number
PL06763120T
Other languages
English (en)
Inventor
Katrin Stange
Original Assignee
Albutec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albutec Gmbh filed Critical Albutec Gmbh
Publication of PL1879909T3 publication Critical patent/PL1879909T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL06763120T 2005-05-13 2006-05-11 Roztwór albuminy pozbawiony cząsteczek stabilizatora PL1879909T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005023155A DE102005023155A1 (de) 2005-05-13 2005-05-13 Albuminlösung
PCT/EP2006/062234 WO2006120226A1 (de) 2005-05-13 2006-05-11 Stabilisatormoleküle-abgereicherte albuminlösung
EP06763120.0A EP1879909B1 (de) 2005-05-13 2006-05-11 Stabilisatormoleküle-abgereicherte albuminlösung

Publications (1)

Publication Number Publication Date
PL1879909T3 true PL1879909T3 (pl) 2015-03-31

Family

ID=36794912

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06763120T PL1879909T3 (pl) 2005-05-13 2006-05-11 Roztwór albuminy pozbawiony cząsteczek stabilizatora

Country Status (14)

Country Link
US (1) US8236927B2 (pl)
EP (1) EP1879909B1 (pl)
JP (1) JP5202305B2 (pl)
CN (1) CN101175766B (pl)
AU (1) AU2006245730B2 (pl)
CA (1) CA2606997C (pl)
DE (1) DE102005023155A1 (pl)
DK (1) DK1879909T3 (pl)
ES (1) ES2526810T3 (pl)
MX (1) MX2007014077A (pl)
PL (1) PL1879909T3 (pl)
PT (1) PT1879909E (pl)
RU (1) RU2420534C2 (pl)
WO (1) WO2006120226A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080078010A (ko) * 2005-12-22 2008-08-26 체에스엘 베링 게엠베하 옥타노에이트-감소된 사람 알부민
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
US8596591B2 (en) * 2009-11-13 2013-12-03 Ergotron, Inc. Vertical spring lift systems
DE112014001309T5 (de) 2013-03-13 2016-01-07 Nxstage Medical, Inc. Single-Pass-Dialyse in Kombination mit Multiple-Pass-Albumin-Dialyse
CN104758924A (zh) * 2014-01-06 2015-07-08 河南省医药科学研究院 包含白蛋白的药物组合物及其用途
EP3119813B1 (fr) * 2014-03-21 2023-01-04 Roquette Frères Procede optimise de decontamination de production de polymeres de glucose et d'hydrolysats de polymeres de glucose
WO2019240255A1 (ja) * 2018-06-15 2019-12-19 扶桑薬品工業株式会社 生殖補助医療用培地
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
JP2024500994A (ja) 2020-12-28 2024-01-10 デボル,インコーポレイテッド タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
ATE211486T1 (de) * 1995-09-22 2002-01-15 Zlb Bioplasma Ag Verfahren zur gewinnung von immunglobulinen aus fraktionen, die bei der fraktionierung von menschlichem blutplasma entstehen
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
GB0200816D0 (en) * 2002-01-15 2002-03-06 Delta Biotechnology Ltd Chiral selection
DE10261910A1 (de) * 2002-12-30 2004-07-15 Polymerics Gmbh Adsorbermaterial für Blut-, Blutplasma- und Albuminreinigungsverfahren
CN100384471C (zh) * 2003-02-13 2008-04-30 奥克塔法马股份有限公司 白蛋白溶液及其制备方法
US20040228829A1 (en) * 2003-03-11 2004-11-18 Roberts Craig P. Plasma detoxification system and methods of use
CN1756587A (zh) * 2003-03-12 2006-04-05 弗雷泽纽斯卡比德国有限公司 重组白蛋白在肝衰竭后透析中的用途

Also Published As

Publication number Publication date
CN101175766B (zh) 2015-04-29
RU2007145933A (ru) 2009-11-10
PT1879909E (pt) 2015-01-05
WO2006120226A8 (de) 2008-03-20
CA2606997C (en) 2015-09-15
RU2420534C2 (ru) 2011-06-10
AU2006245730B2 (en) 2012-01-12
JP2008545626A (ja) 2008-12-18
CN101175766A (zh) 2008-05-07
HK1118296A1 (en) 2009-02-06
AU2006245730A1 (en) 2006-11-16
EP1879909A1 (de) 2008-01-23
MX2007014077A (es) 2008-03-18
CA2606997A1 (en) 2006-11-16
US8236927B2 (en) 2012-08-07
EP1879909B1 (de) 2014-10-29
ES2526810T3 (es) 2015-01-15
US20080269124A1 (en) 2008-10-30
WO2006120226A1 (de) 2006-11-16
DK1879909T3 (en) 2015-01-05
JP5202305B2 (ja) 2013-06-05
DE102005023155A1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
ZA200603961B (en) Hanger arrangement
GB0605712D0 (en) Stabilizer arrangement
EP1832449A4 (en) STABILIZER BAR SOCKET
PT1858330T (pt) Suspensão herbicida
PL1879909T3 (pl) Roztwór albuminy pozbawiony cząsteczek stabilizatora
EP1907710A4 (en) MEANS OF CONSTRUCTION
ZA200701287B (en) Hanger arrangement
DE602006006079D1 (en) Ren
GB0514482D0 (en) Protein
IL191644A0 (en) Aqueous suspension concentrates
ZA200803880B (en) Aqueous suspension concentrates
GB2425338B (en) Connection member
GB0520708D0 (en) Combined hexlobular/cross recess
EP1867792A4 (en) STABILIZER
GB2428267B (en) Support member
GB2424168B (en) Stable aid
ZA200707502B (en) Herbicidal suspension
GB0524396D0 (en) Mirror assembly
GB0511861D0 (en) Proteins
GB0512782D0 (en) Supports
GB2422543B (en) Louse-killing agents
GB0513653D0 (en) Protein stability
ZAF200500579S (en) Connecting member
GB0514788D0 (en) Proteins
GB0514481D0 (en) Proteins